Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Acellular Human Dermal Allograft as a Graft for Nasal Septal Perforation Reconstruction.

Conrad DJ, Zhang H, Côté DWJ.

Plast Reconstr Surg. 2018 Jun;141(6):1517-1524. doi: 10.1097/PRS.0000000000004410.

PMID:
29579028
2.

Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients.

Conrad DJ, Bailey BA, Hardie JA, Bakke PS, Eagan TML, Aarli BB.

PLoS One. 2017 Dec 20;12(12):e0190061. doi: 10.1371/journal.pone.0190061. eCollection 2017.

3.

Three-Dimensional Microbiome and Metabolome Cartography of a Diseased Human Lung.

Garg N, Wang M, Hyde E, da Silva RR, Melnik AV, Protsyuk I, Bouslimani A, Lim YW, Wong R, Humphrey G, Ackermann G, Spivey T, Brouha SS, Bandeira N, Lin GY, Rohwer F, Conrad DJ, Alexandrov T, Knight R, Dorrestein PC.

Cell Host Microbe. 2017 Nov 8;22(5):705-716.e4. doi: 10.1016/j.chom.2017.10.001. Epub 2017 Oct 19.

PMID:
29056429
4.

Characterizing Lung Disease in Cystic Fibrosis with Magnetic Resonance Imaging and Airway Physiology.

Theilmann RJ, Darquenne C, Elliott AR, Bailey BA, Conrad DJ.

PLoS One. 2016 Jun 23;11(6):e0157177. doi: 10.1371/journal.pone.0157177. eCollection 2016.

5.

Using Cystic Fibrosis Therapies for Non-Cystic Fibrosis Bronchiectasis.

ElMaraachli W, Conrad DJ, Wang AC.

Clin Chest Med. 2016 Mar;37(1):139-46. doi: 10.1016/j.ccm.2015.11.005. Epub 2015 Dec 23. Review.

PMID:
26857775
6.

Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome.

Quinn RA, Phelan VV, Whiteson KL, Garg N, Bailey BA, Lim YW, Conrad DJ, Dorrestein PC, Rohwer FL.

ISME J. 2016 Jun;10(6):1483-98. doi: 10.1038/ismej.2015.207. Epub 2015 Dec 1.

7.

Multidimensional clinical phenotyping of an adult cystic fibrosis patient population.

Conrad DJ, Bailey BA.

PLoS One. 2015 Mar 30;10(3):e0122705. doi: 10.1371/journal.pone.0122705. eCollection 2015.

8.

Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.

Rowe SM, Heltshe SL, Gonska T, Donaldson SH, Borowitz D, Gelfond D, Sagel SD, Khan U, Mayer-Hamblett N, Van Dalfsen JM, Joseloff E, Ramsey BW; GOAL Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network.

Am J Respir Crit Care Med. 2014 Jul 15;190(2):175-84. doi: 10.1164/rccm.201404-0703OC.

9.

Cystic fibrosis transmembrane conductance regulator dysfunction in VIP knockout mice.

Alcolado NG, Conrad DJ, Poroca D, Li M, Alshafie W, Chappe FG, Pelis RM, Anini Y, Xu Z, Hamidi S, Said SI, Chappe VM.

Am J Physiol Cell Physiol. 2014 Jul 15;307(2):C195-207. doi: 10.1152/ajpcell.00293.2013. Epub 2014 Jun 4.

10.

Toward implementation of quorum sensing autoinducers as biomarkers for infectious disease states.

Struss AK, Nunes A, Waalen J, Lowery CA, Pullanikat P, Denery JR, Conrad DJ, Kaufmann GF, Janda KD.

Anal Chem. 2013 Mar 19;85(6):3355-62. doi: 10.1021/ac400032a. Epub 2013 Feb 26.

11.

Mucus distribution model in a lung with cystic fibrosis.

Zarei S, Mirtar A, Rohwer F, Conrad DJ, Theilmann RJ, Salamon P.

Comput Math Methods Med. 2012;2012:970809. doi: 10.1155/2012/970809. Epub 2012 Oct 17.

12.

Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa.

Geller DE, Flume PA, Staab D, Fischer R, Loutit JS, Conrad DJ; Mpex 204 Study Group.

Am J Respir Crit Care Med. 2011 Jun 1;183(11):1510-6. doi: 10.1164/rccm.201008-1293OC. Epub 2011 Feb 25.

PMID:
21471106
13.

VIP-dependent increase in F508del-CFTR membrane localization is mediated by PKCε.

Alcolado N, Conrad DJ, Rafferty S, Chappe FG, Chappe VM.

Am J Physiol Cell Physiol. 2011 Jul;301(1):C53-65. doi: 10.1152/ajpcell.00568.2009. Epub 2011 Mar 16.

14.

Frequency of mitochondrial 12S ribosomal RNA variants in an adult cystic fibrosis population.

Conrad DJ, Stenbit AE, Zettner EM, Wick I, Eckhardt C, Hardiman G.

Pharmacogenet Genomics. 2008 Dec;18(12):1095-102. doi: 10.1097/FPC.0b013e328312b072.

PMID:
18830133
15.

Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition.

Chu HW, Balzar S, Westcott JY, Trudeau JB, Sun Y, Conrad DJ, Wenzel SE.

Clin Exp Allergy. 2002 Nov;32(11):1558-65.

PMID:
12569975
16.

Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation.

Wang AC, Dai X, Luu B, Conrad DJ.

Am J Respir Cell Mol Biol. 2001 Jun;24(6):688-93.

PMID:
11415933
17.

Regulation of human 12/15-lipoxygenase by Stat6-dependent transcription.

Conrad DJ, Lu M.

Am J Respir Cell Mol Biol. 2000 Feb;22(2):226-34.

PMID:
10657944
18.

The arachidonate 12/15 lipoxygenases. A review of tissue expression and biologic function.

Conrad DJ.

Clin Rev Allergy Immunol. 1999 Spring-Summer;17(1-2):71-89. Review.

PMID:
10436860
19.

Recent advances in the understanding and treatment of cystic fibrosis.

Resnikoff JR, Conrad DJ.

Curr Opin Pulm Med. 1998 May;4(3):130-4. Review.

PMID:
9675514
20.

Characterization and sequence of an additional 15-lipoxygenase transcript and of the human gene.

Kritzik MR, Ziober AF, Dicharry S, Conrad DJ, Sigal E.

Biochim Biophys Acta. 1997 Jun 26;1352(3):267-81.

PMID:
9224951

Supplemental Content

Loading ...
Support Center